BENGALURU: The Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) and CrisprBits Private Limited have signed a ...

In 2025, CRISPR advanced gene editing with safe, effective therapies and AI tools, marking a shift towards real-world ...

CRISPR became big in 2025, bringing advances for serious Indian health risks, which will continue in the coming year ...

One of the most immediate impacts of AI in medical genetics lies in diagnosis, particularly for rare and complex genetic disorders. Patients with such conditions often face years of uncertainty as ...

It was the best of times, it was the worst of times for research in 2025. | It was the best of times and it was the worst of times for research in 2025. Medical breakthroughs and stunning discoveries ...

Taking this class absolutely transformed what I thought about science and how I thought about myself as a student,” Nellie ...

RNA drugs are a new type of medicine that treat disease by influencing how cells use genetic information, rather than by ...

Preclinical AML studies showed palbociclib plus venetoclax produced stronger, more durable anti‑leukemia activity than venetoclax alone and may overcome resistance.

"Star Trek" remains a science fiction classic, and it's often been a cultural bellwether for our future. These are 10 times ...

Learn more about whether Twist Bioscience Corporation or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The global equine artificial insemination (AI) market is on a robust trajectory, projected to expand from USD 686.7 million ...